SVN-002 (Synnovation Therapeutics)

N/A

Report date: 2025/06/11 10:16:07
NME

Base Information

Drug NameSVN-002 (Synnovation Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitorsAnticancer protein kinase inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynnovation Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynnovation Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A